Opendata, web and dolomites

NanoALS SIGNED

Nanoparticle-based immunization, a novel therapeutic strategy for amyotrophic lateral sclerosis

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 NanoALS project word cloud

Explore the words cloud of the NanoALS project. It provides you a very rough idea of what is the project "NanoALS" about.

systemic    lines    g93a    proteopathies    forms    countries    diseases    cytotoxic    nanoals    considerable    antibodies    quality    mouse    lateral    validation    covers    extracellular    prion    therapies    economy    amyotrophic    neighbouring    surrounding    als    cellular    designed    endogenous    functionalized    encouraging    trials    blocking    multidisciplinary    span    acting    exposed    cerebrospinal    showed    neuro    model    synthesis    strategy    neuronal    cell    bind    fluid    life    patients    plga    nanoconstructs    active    motor    aberrantly    worldwide    death    toxicity    gold    sclerosis    misfolding    preventing    therapeutic    optimizing    benefits    isoforms    extends    nanoparticles    cells    uptaken    conformations    population    nanoscience    models    clinical    manner    released    reuptake    secreted    disease    as    alzheimer    prevalence    aggregate    sod1    immunization    folded    media    maximize    neurodegenerative    representing    prone    therapy    epitopes    misfolded    proteins    passive    scaffolds    neuron   

Project "NanoALS" data sheet

The following table provides information about the project.

Coordinator
UNIVERSIDAD DE ZARAGOZA 

Organization address
address: CALLE PEDRO CERBUNA 12
city: ZARAGOZA
postcode: 50009
website: www.unizar.es

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Total cost 158˙121 €
 EC max contribution 158˙121 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2016
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2018
 Duration (year-month-day) from 2018-03-01   to  2020-02-29

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UNIVERSIDAD DE ZARAGOZA ES (ZARAGOZA) coordinator 158˙121.00

Map

 Project objective

As the life span of the population extends, the prevalence of neurodegenerative diseases is rapidly increasing representing a considerable impact for the quality of life and economy of many countries worldwide. Most of these diseases, including Amyotrophic lateral sclerosis (ALS) are currently considered as proteopathies, where some proteins (SOD1 in the case of ALS) adopt misfolded conformations prone to aggregate and cause cellular toxicity and motor neuron death. Moreover, these proteins are secreted to extracellular media contributing to the widespread of the disease in a prion-like manner, by acting as scaffolds for the misfolding of endogenous proteins when uptaken by surrounding cells. The aim of NanoALS is to bring together Neuro and Nanoscience fields to design a novel passive immunization therapy to target the misfolded SOD1 released into cerebrospinal fluid in ALS. It will be based on the systemic delivery of gold and PLGA nanoparticles functionalized with specific antibodies against the different isoforms of misfolded SOD1. These nanoconstructs will bind the different aberrantly folded SOD1 forms preventing their reuptake by neighbouring cells and blocking the cytotoxic epitopes exposed after misfolding. The multidisciplinary work program in NanoALS covers the synthesis of the functionalized nanoconstructs as well as validation of their therapeutic potential in neuronal cell lines and in the SOD1-G93A mouse model of ALS. Immunization against misfolded extracellular proteins has showed an encouraging success in ALS mouse models and in recent clinical trials with Alzheimer patients. Optimizing the delivery systems and targeting different misfolded isoforms as well as the active exploitation and dissemination strategy designed for NanoALS will maximize the benefits of these therapies both in ALS and other proteopathies.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "NANOALS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "NANOALS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

SIMIS (2020)

Strongly Interacting Mass Imbalanced Superfluid with ultracold fermions

Read More  

LISEDIDYS (2020)

Limit sets of discrete dynamical systems

Read More  

iRhomADAM (2020)

Uncovering the role of the iRhom2-ADAM17 interaction in inflammatory signalling

Read More